If a life science company includes people from outside the industry in its board, it can turn into a huge advantage – even if they don't have expert knowledge on the industry, according to business commentator Jens Christian Hansen.
He sees a clear tendency in Tuesday's announcements that Novo Nordisk has nominated Danish utility Ørsted's former President & CEO Henrik Poulsen for its company board at the same as Google's Country Director for Denmark, Malou Aamund, enters WS Audiology's board.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.